Ovarian Stimulation Completed Phase 3 Trials for Luteinizing hormone (DB14741)

IndicationStatusPhase
DBCOND0040254 (Ovarian Stimulation)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01121991A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive TechnologiesTreatment
NCT01037699Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist CyclesTreatment